Announcement PDF Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity RESONANCE HEALTH LIMITED ABN 96 006 762 492 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of director Aaron Brinkworth Date of last notice 06 September 2023 Part 1 - Change of director's relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) N/A Date of change (a) 04 April 2025 (b) 07 April 2025 (c) 08 April 2025 (d) 09 April 2025 No. of securities held prior to change 300,000 - ORDINARY FULLY PAID SHARES Class ORDINARY FULLY PAID SHARES Number acquired (a) 8,204 - ORDINARY FULLY PAID SHARES (b) 272,885 - ORDINARY FULLY PAID SHARES (c) 267,083 - ORDINARY FULLY PAID SHARES (d) 259,475 - ORDINARY FULLY PAID SHARES Number disposed (a) NIL (b) NIL (c) NIL (d) NIL Value/Consideration (a) $303 - ORDINARY FULLY PAID SHARES (b) $9,959 - ORDINARY FULLY PAID SHARES (c) $19,454 - ORDINARY FULLY PAID SHARES (d) $520 - ORDINARY FULLY PAID SHARES No. of securities held after change 1,107,647 - ORDINARY FULLY PAID SHARES Nature of change (a) On market purchase (b) On market purchase (c) On market purchase (d) On market purchase Part 2 - Change of director's relevant interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Appendix 3Y Change of Director's Interest Notice disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change N/A Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Part 3 - +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2